INVO insider filings

INVO Bioscience, Inc. — 41 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-05-22. Screen INVO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for INVO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — INVO Bioscience, Inc.

FiledFormInsiderReported transactionsSource
2023-05-224Shum Steve — Chief Executive Officer, DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2023-05-224Ryan Barbara — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2023-05-224Messina Rebecca — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2023-05-224Campbell Michael Jos. — Chief Operating Officer, DirectorGrant/award (A): 83,000 (derivative) @ $0EDGAR
2023-05-224Szot Matthew K — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2023-05-224Goren Andrea — Chief Financial OfficerGrant/award (A): 81,000 (derivative) @ $0EDGAR
2023-05-224DAVIS TRENT D — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2022-06-034Shum Steve — Chief Executive Officer, DirectorPurchase (P): 58,885 @ $0.95EDGAR
2022-06-034Ryan Barbara — DirectorPurchase (P): 10,526 @ $0.95EDGAR
2022-06-034Segal Jeffrey — DirectorPurchase (P): 9,211 @ $0.95EDGAR
2022-06-034Campbell Michael Jos. — Chief Operating Officer, DirectorPurchase (P): 10,526 @ $0.95EDGAR
2022-06-034Messina Rebecca — DirectorPurchase (P): 9,868 @ $0.95EDGAR
2022-06-034Doody Kevin — Medical Director, DirectorPurchase (P): 177,306 @ $0.95EDGAR
2022-06-034Szot Matthew K — DirectorPurchase (P): 14,474 @ $0.95EDGAR
2022-06-034Goren Andrea — Chief Financial OfficerPurchase (P): 52,632 @ $0.95EDGAR
2022-06-034DAVIS TRENT D — DirectorPurchase (P): 11,184 @ $0.95EDGAR
2022-01-184Doody Kevin — Medical Director, DirectorGrant/award (A): 7,480 @ $0 · Grant/award (A): 9,088 (derivative) @ $0EDGAR
2022-01-184Segal Jeffrey — DirectorGrant/award (A): 8,034 @ $0 · Grant/award (A): 9,762 (derivative) @ $0EDGAR
2022-01-184Campbell Michael Jos. — Chief Operating Officer, DirectorGrant/award (A): 15,236 @ $0 · Grant/award (A): 18,513 (derivative) @ $0EDGAR
2022-01-184Shum Steve — Chief Executive Officer, DirectorGrant/award (A): 20,111 @ $0 · Grant/award (A): 57,018 (derivative) @ $0EDGAR
2022-01-184Messina Rebecca — DirectorGrant/award (A): 8,311 @ $0 · Grant/award (A): 10,098 (derivative) @ $0EDGAR
2022-01-184Ryan Barbara — DirectorGrant/award (A): 8,588 @ $0 · Grant/award (A): 10,435 (derivative) @ $0EDGAR
2022-01-184Szot Matthew K — DirectorGrant/award (A): 10,250 @ $0 · Grant/award (A): 12,454 (derivative) @ $0EDGAR
2022-01-184Goren Andrea — Chief Financial OfficerGrant/award (A): 5,361 @ $0 · Grant/award (A): 15,197 (derivative) @ $0EDGAR
2022-01-184DAVIS TRENT D — DirectorGrant/award (A): 8,865 @ $0 · Grant/award (A): 10,771 (derivative) @ $0EDGAR
2021-10-124AWM Investment Company, Inc. — 10% ownerHoldings only — no transactions reportedEDGAR
2021-10-074Shum Steve — Chief Executive Officer, DirectorPurchase (P): 30,674 @ $3.26EDGAR
2021-10-074Goren Andrea — Chief Financial OfficerPurchase (P): 30,674 @ $3.26EDGAR
2021-05-134Messina Rebecca — DirectorGrant/award (A): 4,806 @ $0 · Grant/award (A): 6,239 (derivative) @ $0EDGAR
2021-05-124AWM Investment Company, Inc. — 10% ownerPurchase (P): 1,000 @ $3.76EDGAR
2021-05-114AWM Investment Company, Inc. — 10% ownerPurchase (P): 15,000 @ $4.08 · Purchase (P): 27,811 @ $4.08 · Purchase (P): 13,146 @ $4.00 · Purchase (P): 5,800 @ $3.97 · Purchase (P): 17,152 @ $3.95 · Purchase (P): 322 @ $3.85 · +7 moreEDGAR
2021-01-054Shum Steve — Chief Executive Officer, DirectorGrant/award (A): 180,000 (derivative) @ $0EDGAR
2021-01-054Segal Jeffrey — DirectorGrant/award (A): 8,838 @ $0 · Grant/award (A): 11,823 (derivative) @ $0EDGAR
2021-01-054Ryan Barbara — DirectorGrant/award (A): 10,148 @ $0 · Grant/award (A): 13,574 (derivative) @ $0EDGAR
2021-01-054Doody Kevin — Medical Director, DirectorGrant/award (A): 8,184 @ $0 · Grant/award (A): 10,947 (derivative) @ $0EDGAR
2021-01-054Campbell Michael Jos. — Chief Operating Officer, DirectorGrant/award (A): 165,000 (derivative) @ $0EDGAR
2021-01-054Szot Matthew K — DirectorGrant/award (A): 12,112 @ $0 · Grant/award (A): 16,202 (derivative) @ $0EDGAR
2021-01-054DAVIS TRENT D — DirectorGrant/award (A): 10,475 @ $0 · Grant/award (A): 14,012 (derivative) @ $0EDGAR
2020-12-014Segal Jeffrey — DirectorGrant/award (A): 1,137 @ $0 · Grant/award (A): 1,137 (derivative) @ $0EDGAR
2020-12-014Ryan Barbara — DirectorGrant/award (A): 2,317 @ $0 · Grant/award (A): 2,317 (derivative) @ $0EDGAR
2020-12-014Szot Matthew K — DirectorGrant/award (A): 2,339 @ $0 · Grant/award (A): 2,339 (derivative) @ $0EDGAR

Recent 8-K events — INVO Bioscience, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-288-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-178-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-248-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-258-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
EDGAR
2026-06-228-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-028-K4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-028-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=INVO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs